missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 30141030

Nicotinic Acetylcholine R alpha 1/CHRNA1 Antibody (mAb 192), CoraFluor™ 1, Novus Biologicals™

Rat Monoclonal Antibody

Brand:  Novus Biologicals (Bio-Techne) NBP2-81070CL1

Product Code. 30141030

  • £755.00 / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

Nicotinic Acetylcholine R alpha 1/CHRNA1 Monoclonal antibody specifically detects Nicotinic Acetylcholine R alpha 1/CHRNA1 in Human,Mouse,Rat samples. It is validated for ELISA,Western Blot,Neutralization,Immunocytochemistry/Immunofluorescence
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Nicotinic Acetylcholine R alpha 1/CHRNA1
Monoclonal
CoraFluor 1
acetylcholine receptor subunit alpha, ACHRA, ACHRD, CHNRA, cholinergic receptor, nicotinic, alpha 1 (muscle), CHRNA, CMS2A, FCCMS, nicotinic acetylcholine receptor alpha subunit, nicotinic cholinergic receptor alpha 1, nicotinic, alpha polypeptide 1 (muscle), SCCMS
Human muscle AChR.
0.1 mL
Neuroscience
1134
Store at 4°C in the dark. Do not freeze.
IgG2b κ
ELISA, Western Blot, Neutralization, Immunocytochemistry/Immunofluorescence
mAb 192
PBS
Rat
Protein A purified
RUO
Primary
Human, Mouse, Rat
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.